BIO RAD LABS INC's ticker is BIOB and the CUSIP is 090572108. A total of 7 filers reported holding BIO RAD LABS INC in Q4 2023. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2024 | $45,352 | -13.2% | 160 | 0.0% | 0.00% | 0.0% |
| Q1 2024 | $52,262 | +3.4% | 160 | 0.0% | 0.00% | 0.0% |
| Q4 2023 | $50,526 | -11.1% | 160 | 0.0% | 0.00% | 0.0% |
| Q3 2023 | $56,808 | -4.3% | 160 | 0.0% | 0.00% | 0.0% |
| Q2 2023 | $59,374 | -20.0% | 160 | 0.0% | 0.00% | 0.0% |
| Q1 2023 | $74,254 | +14.7% | 160 | 0.0% | 0.00% | 0.0% |
| Q4 2022 | $64,744 | -11.3% | 160 | 0.0% | 0.00% | -50.0% |
| Q3 2022 | $73,000 | – | 160 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| CSS LLC/IL | 13,588 | $7,004,000 | 0.33% |
| Gemmer Asset Management LLC | 299 | $152,000 | 0.03% |
| Renaissance Technologies | 3,000 | $1,524,000 | 0.00% |
| OSAIC HOLDINGS, INC. | 51 | $26,000 | 0.00% |
| MORGAN STANLEY | 692 | $353,000 | 0.00% |
| WELLS FARGO & COMPANY/MN | 56 | $29,000 | 0.00% |
| CONCOURSE FINANCIAL GROUP SECURITIES, INC. | 0 | $0 | 0.00% |
| UBS Group AG | 303 | $154,000 | 0.00% |